Nucleoporin NUP153 Phenylalanine-Glycine Motifs Engage a Common Binding Pocket within the HIV-1 Capsid Protein to Mediate Lentiviral Infectivity
Open accessThe DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.
Abstract
Lentiviruses can infect non-dividing cells, and various cellular transport proteins provide crucial functions for lentiviral nuclear entry and integration. We previously showed that the viral capsid (CA) protein mediated the dependency on cellular nucleoporin (NUP) 153 during HIV-1 infection, and now demonstrate a direct interaction between the CA N-terminal domain and the phenylalanine-glycine (FG)-repeat enriched NUP153 C-terminal domain (NUP153(C)). NUP153(C) fused to the effector domains of the rhesus Trim5α restriction factor (Trim-NUP153(C)) potently restricted HIV-1, providing an intracellular readout for the NUP153(C)-CA interaction during retroviral infection. Primate lentiviruses and equine infectious anemia virus (EIAV) bound NUP153(C) under these conditions, results that correlated with direct binding between purified proteins in vitro. These binding phenotypes moreover correlated with the requirement for endogenous NUP153 protein during virus infection. Mutagenesis experiments concordantly identified NUP153(C) and CA residues important for binding and lentiviral infectivity. Different FG motifs within NUP153(C) mediated binding to HIV-1 versus EIAV capsids. HIV-1 CA binding mapped to residues that line the common alpha helix 3/4 hydrophobic pocket that also mediates binding to the small molecule PF-3450074 (PF74) inhibitor and cleavage and polyadenylation specific factor 6 (CPSF6) protein, with Asn57 (Asp58 in EIAV) playing a particularly important role. PF74 and CPSF6 accordingly each competed with NUP153(C) for binding to the HIV-1 CA pocket, and significantly higher concentrations of PF74 were needed to inhibit HIV-1 infection in the face of Trim-NUP153(C) expression or NUP153 knockdown. Correlation between CA mutant viral cell cycle and NUP153 dependencies moreover indicates that the NUP153(C)-CA interaction underlies the ability of HIV-1 to infect non-dividing cells. Our results highlight similar mechanisms of binding for disparate host factors to the same region of HIV-1 CA during viral ingress. We conclude that a subset of lentiviral CA proteins directly engage FG-motifs present on NUP153 to affect viral nuclear import.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Diverse lentiviruses bind NUP153C. (A) Transduction efficiencies of retroviral GFP reporter viruses in Trim-NUP153C expressing cells normalized to infection in mock transduced cells, which were set to 100%. Results are the geometric mean of 4 experiments, with error bars denoting 95% confidence intervals. (B) HA-NUP153C expressed in 293T cells was pulled down by the indicated his-tagged retroviral CAN proteins. Captured proteins resolved by SDS-PAGE were western blotted with antibody 3F10 alongside a standard curve of input protein. The results are an average of 5 experiments, with error bars denoting 95% confidence intervals. A representative western blot is shown. (C) SYPRO Ruby detection of retroviral CAN pull-down of purified NUP153C. The results are an average of two experiments, with error bars denoting standard error; one representative gel is shown. (D) (left) Retroviral infectivities in HOS cells knocked down for NUP153 expression as compared to cells treated with a non-targeting short interfering (si) RNA control [19]. The results are the geometric mean of at least 4 experiments, with error bars denoting 95% confidence intervals. (right) Western blot detection of control or NUP153 knockdown HOS cells with antibody mab414, which also detects NUP358. (E) Scatter plot comparing relative retroviral infectivities under each condition.](https://figures.cochat.ai/paper-figures/ed918781228e48e0ab7e509b190f5345/nucleoporin-nup153-phenylalanine-glycine-motifs-engage-a-common-binding-pocket-figure-3.jpg)









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HIV-1 nuclear import is mediated via the viral capsid, which interacts directly with several components of the cellular nuclear import machinery, including the nuclear pore complex components Nup153 and Nup358 (REF.76–78).”
From Structure and function of retroviral integrase (2022) · cites this paper as [78]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“recent studies have shown that HIV-1 CA can enter the nucleus of nondividing cells with the help of host factors like the cleavage and polyadenylation specificity factor 6 (CPSF6) and nuclear pore complex (NPC) proteins, NUP153 and NUP358 (Matreyek et al. 2013, Buffone et al. 2018, Bejarano et al. 2019, Burdick et al. 2020, Dharan et al. 2020, Selyutina et al. 2020, Zila et al. 2021).”
From Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication (2026) · cites this paper as Matreyek et al. 2013
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Cleavage and polyadenylation specificity factor 6 (CPSF6), which is a component of the cellular pre-mRNA cleavage and polyadenylation machinery79, binds the same region of capsid as Nup153 (REF.78,80).”
From Structure and function of retroviral integrase (2022) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
The Role of Mononuclear Phagocytes in HTLV-III/LAV Infection
Gartner, S., Markovits, P., Markovitz, D. M., Kaplan, M. H., Gallo, R. C., & Popovic, M. (1986) · Science · doi:10.1126/science.3014648 · Cited by 1,807
Identification of host proteins required for HIV infection through a functional genomic screen
Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N., Engelman, A., Xavier, R. J., Lieberman, J., & Elledge, S. J. (2008) · Science · doi:10.1126/science.1152725 · Cited by 1,449 · cited 1×
“…been shown to participate in HIV-1 nuclear import, with perhaps the most promising candidates emerging from a series of genome-wide RNA interference (RNAi) screens; factors identified in more than one of these screens include transportin-3 (TNPO3 or TRN-SR2), NUP358 (RANBP2), and NUP153 [15–17].”
BackgroundSelf-citationGlobal Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication
König, R., Zhou, Y., Elleder, D., Diamond, T. L., Bonamy, G. M. C., Irelan, J. T., Chiang, C.-Y., Tu, B. P., De Jesus, P. D., Lilley, C. E., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.032 · Cited by 960
Integration of murine leukemia virus DNA depends on mitosis.
Roe, T., Reynolds, T. C., Yu, G., & Brown, P. O. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05858.x · Cited by 921
Heinzinger, N. K., Bukinsky, M. I., Haggerty, S. A., Ragland, A. M., Kewalramani, V, Lee, M. A., Gendelman, H. E., Ratner, L., Stevenson, M., & Emerman, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7311 · Cited by 854 · cited 1×
“While relatively intact cores enter the cell upon viral-cell membrane fusion, little if any CA remains associated with the PIC within the nucleus [33–37].”
BackgroundMature HIV-1 capsid structure by cryo-electron microscopy and all-atom molecular dynamics
Zhao, G., Perilla, J. R., Yufenyuy, E. L., Meng, X., Chen, B., Ning, J., Ahn, J., Gronenborn, A. M., Schulten, K., Aiken, C., et al. (2013) · Nature · doi:10.1038/nature12162 · Cited by 801
Lewis, P. F., & Emerman, M. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.510-516.1994 · Cited by 797
Willey, R. L., Smith, D. H., Lasky, L. A., Theodore, T. S., Earl, P. L., Moss, B., Capon, D. J., & Martin, M. A. (1988) · Journal of Virology · doi:10.1128/jvi.62.1.139-147.1988 · Cited by 751
Stremlau, M., Perron, M., Lee, M., Li, Y., Song, B., Javanbakht, H., Diaz-Griffero, F., Anderson, D. J., Sundquist, W. I., & Sodroski, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509996103 · Cited by 739
Research works printed but not linked: 1
- N Loewen, 2003, FIV Vectors, Method Mol Biol, 229, 251
Cited by
Items 101–200 of 293
Hou, Z., Shen, Y., Fronik, S., Shen, J., Shi, J., Xu, J., Chen, L., Hardenbrook, N. J., Thompson, C., Neumann, S., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02054-z · Cited by 40
Self-citationCapsid–host interactions for HIV-1 ingress
Jang, S., & Engelman, A. (2023) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00048-22 · Cited by 42
Self-citationAnalysis of CA Content and CPSF6 Dependence of Early HIV-1 Replication Complexes in SupT1-R5 Cells
Zila, V., Müller, T. G., Laketa, V., Müller, B., & Kräusslich, H.-G. (2019) · mBio · doi:10.1128/mbio.02501-19 · Cited by 41
Viral mechanisms for docking and delivering at nuclear pore complexes
Flatt, J. W., & Greber, U. F. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.05.008 · Cited by 37
Strategies for Targeting Retroviral Integration for Safer Gene Therapy: Advances and Challenges
Yoder, K. E., Rabe, A. J., Fishel, R. A., & Larue, R. C. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.662331 · Cited by 41
Shi, J., Zhou, J., Halambage, U. D., Shah, V. B., Burse, M. J., Wu, H., Blair, W. S., Butler, S. L., & Aiken, C. (2014) · Journal of Virology · doi:10.1128/jvi.01411-14 · Cited by 37
Gene Therapy Strategies to Exploit TRIM Derived Restriction Factors against HIV-1
Chan, E., Towers, G. J., & Qasim, W. (2014) · Viruses · doi:10.3390/v6010243 · Cited by 42
Wang, L., Casey, M. C., Vernekar, S. K. V., Sahani, R. L., Kirby, K. A., Du, H., Zhang, H., Tedbury, P. R., Xie, J., Sarafianos, S. G., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.07.016 · Cited by 36
McCarthy, K. R., Kirmaier, A., Autissier, P., & Johnson, W. E. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005085 · Cited by 38
Let me in: Control of HIV nuclear entry at the nuclear envelope
Bhargava, A., Lahaye, X., & Manel, N. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.02.006 · Cited by 35
Toward Structurally Novel and Metabolically Stable HIV-1 Capsid-Targeting Small Molecules
Vernekar, S. K. V., Sahani, R. L., Casey, M. C., Kankanala, J., Wang, L., Kirby, K. A., Du, H., Zhang, H., Tedbury, P. R., Xie, J., et al. (2020) · Viruses · doi:10.3390/v12040452 · Cited by 35
Impact of LEDGIN treatment during virus production on residual HIV-1 transcription
Vansant, G., Vranckx, L. S., Zurnic, I., Looveren, D. V., de Velde, P. V., Nobles, C. L., Gijsbers, R., Christ, F., & Debyser, Z. (2019) · Retrovirology · doi:10.1186/s12977-019-0472-3 · Cited by 33
Viral Appropriation: Laying Claim to Host Nuclear Transport Machinery
Tessier, T. M., Dodge, M. J., Prusinkiewicz, M. A., & Mymryk, J. S. (2019) · Cells · doi:10.3390/cells8060559 · Cited by 34
Absence of cGAS-mediated type I IFN responses in HIV-1–infected T cells
Elsner, C., Ponnurangam, A., Kazmierski, J., Zillinger, T., Jansen, J., Tödt, D., Döhner, K., Xu, S., Ducroux, A., Kriedemann, N., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002481117 · Cited by 33
HIV-1 capsid and viral DNA integration
Dwivedi, R., Prakash, P., Kumbhar, B. V., Balasubramaniam, M., & Dash, C. (2023) · mBio · doi:10.1128/mbio.00212-22 · Cited by 34
Biomolecular condensates: insights into early and late steps of the HIV-1 replication cycle
Nunzio, F. D., Uversky, V. N., & Mouland, A. J. (2023) · Retrovirology · doi:10.1186/s12977-023-00619-6 · Cited by 31
Jang, S., Bedwell, G. J., SINGH, S. P., Yu, H. J., Arnarson, B., Singh, P. K., Radhakrishnan, R., Douglas, A. W., Ingram, Z., Freniere, C., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae769 · Cited by 30
Self-citationStructural and mechanistic bases for resistance of the M66I capsid variant to lenacapavir
Briganti, L., Annamalai, A. S., Bester, S. M., Wei, G., Andino-Moncada, J. R., Singh, S. P., Kleinpeter, A. B., Tripathi, M., Nguyen, B., Radhakrishnan, R., et al. (2025) · mBio · doi:10.1128/mbio.03613-24 · Cited by 29
Self-citationXie, L., Chen, L., Zhong, C., Yu, T., Ju, Z., Wang, M., Xiong, H., Zeng, Y., Wang, J., Hu, H., et al. (2020) · Retrovirology · doi:10.1186/s12977-020-00524-2 · Cited by 30
The Role of Capsid in HIV-1 Nuclear Entry
Guedán, A., Caroe, E. R., Barr, G. C. R., & Bishop, K. N. (2021) · Viruses · doi:10.3390/v13081425 · Cited by 33
Chemical profiling of HIV-1 capsid-targeting antiviral PF74
Wang, L., Casey, M. C., Vernekar, S. K. V., Ha, T., Sahani, R. L., Kirby, K. A., Du, H., Hachiya, A., Zhang, H., Tedbury, P. R., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112427 · Cited by 30
Novel HIV-1 capsid-targeting small molecules of the PF74 binding site
Wang, L., Casey, M. C., Vernekar, S. K. V., Sahani, R. L., Kankanala, J., Kirby, K. A., Du, H., Hachiya, A., Zhang, H., Tedbury, P. R., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112626 · Cited by 28
Xu, S., Sun, L., Dick, A., Zalloum, W. A., Huang, T., Meuser, M. E., Zhang, X., Tao, Y., Cherukupalli, S., Ding, D., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113903 · Cited by 28
Cryo-electron Microscopy Reveals the Structure of the Nuclear Pore Complex
Tai, L., Yin, G., Sun, F., & Zhu, Y. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168051 · Cited by 31
TRIM5α SPRY/coiled-coil interactions optimize avid retroviral capsid recognition
Roganowicz, M., Keceli, S. K., Mukherjee, S., Plewka, J., Alam, S. L., Skorupka, K. A., Wan, Y., Dawidowski, D., Cafiso, D. S., Ganser‐Pornillos, B. K., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006686 · Cited by 29
Ciuffi, A. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.02.013 · Cited by 27
HIV-1 Gag: An Emerging Target for Antiretroviral Therapy
Tedbury, P. R., & Freed, E. O. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_436 · Cited by 39
Digoxin reveals a functional connection between HIV-1 integration preference and T-cell activation
Zhyvoloup, A., Melamed, A., Anderson, I., Planas, D., Lee, C.-H., Kriston-Vizi, J., Ketteler, R., Merritt, A. T., Routy, J., Ancuța, P., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006460 · Cited by 28
Schaller, T., Bulli, L., Pollpeter, D., Betancor, G., Kutzner, J., Apolonia, L., Herold, N., Burk, R., & Malim, M. H. (2017) · Journal of Virology · doi:10.1128/jvi.00463-17 · Cited by 27
The HIV-1 Capsid: From Structural Component to Key Factor for Host Nuclear Invasion
Scoca, V., & Nunzio, F. D. (2021) · Viruses · doi:10.3390/v13020273 · Cited by 28
Lucic, B., de Castro, I. J., & Lušić, M. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a039446 · Cited by 29
Mamede, J. I., Damond, F., de Bernardo, A., Matheron, S., Descamps, D., Battini, J., Sitbon, M., & Courgnaud, V. (2017) · Scientific Reports · doi:10.1038/srep45214 · Cited by 25
Characterization of HIV-1 uncoating in human microglial cell lines
Ingram, Z., TAYLOR, M., Okland, G., Martin, R., & Hulme, A. E. (2020) · Virology Journal · doi:10.1186/s12985-020-01301-5 · Cited by 25
A Tag‐Free Platform for Synthesis and Screening of Cyclic Peptide Libraries
Bruce, A., Adebomi, V., Czabala, P., Palmer, J. M., McFadden, W. M., Lorson, Z. C., Slack, R. L., Bhardwaj, G., Sarafianos, S. G., & Raj, M. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202320045 · Cited by 24
The Viral Capsid: A Master Key to Access the Host Nucleus
Blanco-Rodriguez, G., & Nunzio, F. D. (2021) · Viruses · doi:10.3390/v13061178 · Cited by 24
The Role of Capsid in the Early Steps of HIV-1 Infection: New Insights into the Core of the Matter
AlBurtamani, N., Paul, A., & Fassati, A. (2021) · Viruses · doi:10.3390/v13061161 · Cited by 23
Impact of Chromatin on HIV Replication
Agosto, L. M., Gagné, M., & Henderson, A. J. (2015) · Genes · doi:10.3390/genes6040957 · Cited by 24
The Multifaceted Contributions of Chromatin to HIV-1 Integration, Transcription, and Latency
Crignis, E. D., & Mahmoudi, T. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.08.006 · Cited by 24
HIV Capsid Inhibitors Beyond PF74
McArthur, C. P., Gallazzi, F., Quinn, T. P., & Singh, K. (2019) · Diseases · doi:10.3390/diseases7040056 · Cited by 24
Visualizing HIV-1 Capsid and Its Interactions with Antivirals and Host Factors
Wilbourne, M., & Zhang, P. (2021) · Viruses · doi:10.3390/v13020246 · Cited by 24
Wang, W., Zhou, J., Halambage, U. D., Jurado, K. A., Jamin, A. V., Wang, Y., Engelman, A., & Aiken, C. (2017) · Journal of Virology · doi:10.1128/jvi.02155-16 · Cited by 22
Self-citationStructural basis for Fullerene geometry in a human endogenous retrovirus capsid
Acton, O., Grant, T., Nicastro, G., Ball, N. J., Goldstone, D. C., Robertson, L. E., Sader, K., Nans, A., Ramos, A., Stoye, J. P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13786-y · Cited by 22
Localization and functions of native and eGFP-tagged capsid proteins in HIV-1 particles
Francis, A. C., Cereseto, A., Singh, P. K., Shi, J., Poeschla, E. M., Engelman, A., Aiken, C., & Melikyan, G. B. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010754 · Cited by 22
Self-citationEschbach, J. E., Elliott, J. L., Li, W., Zadrozny, K. K., Davis, K., Mohammed, S. J., Lawson, D. Q., Pornillos, O., Engelman, A., & Kutluay, S. B. (2020) · Journal of Virology · doi:10.1128/jvi.00984-20 · Cited by 22
Self-citationImaging Viral Infection by Fluorescence Microscopy: Focus on HIV-1 Early Stage
Mukherjee, S., Boutant, E., Réal, É., Mély, Y., & Anton, H. (2021) · Viruses · doi:10.3390/v13020213 · Cited by 22
Meuser, M. E., Reddy, P. A. N., Dick, A., Maurancy, J. M., Salvino, J. M., & Cocklin, S. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01810 · Cited by 22
Canales, E., Tse, W. C., Schroeder, S. D., Chou, C., Liu, Q., Zhang, J., Lazerwith, S. E., Morganelli, P., Saito, R. D., Brizgys, G., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01625 · Cited by 24
HIV-1 CA Inhibitors Are Antagonized by Inositol Phosphate Stabilization of the Viral Capsid in Cells
Sowd, G. A., Shi, J., & Aiken, C. (2021) · Journal of Virology · doi:10.1128/jvi.01445-21 · Cited by 20
Gres, A. T., Kirby, K. A., McFadden, W. M., Du, H., Liu, D., Xu, C., Bryer, A. J., Perilla, J. R., Shi, J., Aiken, C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41197-7 · Cited by 21
Regulation of Plant Immunity by Nuclear Membrane-Associated Mechanisms
Fang, Y., & Gu, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.771065 · Cited by 23
Teaching old dogmas new tricks: recent insights into the nuclear import of HIV-1
Dharan, A., & Campbell, E. M. (2022) · Current Opinion in Virology · doi:10.1016/j.coviro.2022.101203 · Cited by 21
Zhang, X., Sun, L., Meuser, M. E., Zalloum, W. A., Xu, S., Huang, T., Cherukupalli, S., Jiang, X., Ding, X., Tao, Y., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113848 · Cited by 20
Emerging role of cyclophilin A in HIV-1 infection: from producer cell to the target cell nucleus
Padron, A., Prakash, P., Pandhare, J., Luban, J., Aiken, C., Balasubramaniam, M., & Dash, C. (2023) · Journal of Virology · doi:10.1128/jvi.00732-23 · Cited by 20
Eschbach, J. E., Puray‐Chavez, M., Mohammed, S., Wang, Q., Xia, M., Huang, L., Shan, L., & Kutluay, S. B. (2024) · mBio · doi:10.1128/mbio.00348-24 · Cited by 20
The Long Terminal Repeat Retrotransposons Tf1 and Tf2 of Schizosaccharomyces pombe
Esnault, C., & Levin, H. L. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0040-2014 · Cited by 19
Exploring HIV-1 Maturation: A New Frontier in Antiviral Development
McGraw, A., Hillmer, G., Mehedincu, S. M., Hikichi, Y., Gagliardi, S., Narayan, K., Tibebe, H., Marquez, D., Bose, L. M., Keating, A., et al. (2024) · Viruses · doi:10.3390/v16091423 · Cited by 20
The Human Immunodeficiency Virus Capsid Is More Than Just a Genome Package
James, L. C., & Jacques, D. A. (2018) · Annual Review of Virology · doi:10.1146/annurev-virology-092917-043430 · Cited by 18
Multiple Pathways To Avoid Beta Interferon Sensitivity of HIV-1 by Mutations in Capsid
Sultana, T., Mamede, J. I., Saito, A., Ode, H., Nohata, K., Cohen, R., Nakayama, E. E., Iwatani, Y., Yamashita, M., Hope, T. J., et al. (2019) · Journal of Virology · doi:10.1128/jvi.00986-19 · Cited by 18
Towards a Functional Cure of HIV-1: Insight Into the Chromatin Landscape of the Provirus
Janssens, J., Bruggemans, A., Christ, F., & Debyser, Z. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.636642 · Cited by 18
The transmembrane nucleoporin Pom121 ensures efficient HIV-1 pre-integration complex nuclear import
Guo, J., Liu, X., Wu, C., Hu, J., Peng, K., Wu, L. J., Xiong, S., & Dong, C. (2018) · Virology · doi:10.1016/j.virol.2018.06.008 · Cited by 19
Sowd, G. A., Shi, J., Fulmer, A. N., & Aiken, C. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011423 · Cited by 18
Ingram, Z., Kline, C. E., Hughson, A. K., Singh, P. K., Fischer, H. L., Radhakrishnan, R., Sowd, G. A., dos Santos, N. F. B., Ganser‐Pornillos, B. K., Watkins, S. C., et al. (2025) · mBio · doi:10.1128/mbio.00169-25 · Cited by 17
Self-citationControl of yeast retrotransposons mediated through nucleoporin evolution
Rowley, P. A., Patterson, K., Sandmeyer, S. B., & Sawyer, S. L. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007325 · Cited by 17
Craveur, P., Gres, A. T., Kirby, K. A., Liu, D., Hammond, J. A., Deng, Y., Forli, S., Goodsell, D. S., Williamson, J. R., Sarafianos, S. G., et al. (2019) · mBio · doi:10.1128/mbio.02858-18 · Cited by 17
Xu, S., Sun, L., Zalloum, W. A., Zhang, X., Huang, T., Ding, D., Tao, Y., Zhao, F., Gao, S., Kang, D., et al. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.06.034 · Cited by 18
Gruenke, P. R., Aneja, R., Welbourn, S., Ukah, O. B., Sarafianos, S. G., Burke, D. H., & Lange, M. J. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1293 · Cited by 16
Manhas, S., Ma, L., & Measday, V. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky109 · Cited by 16
Derivation of simian tropic HIV-1 infectious clone reveals virus adaptation to a new host
Schmidt, F., Keele, B. F., Prete, G. Q. D., Voronin, D., Fennessey, C. M., Soll, S. J., Kane, M., Raymond, A., Gifford, R. J., KewalRamani, V. N., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818059116 · Cited by 16
Interaction of influenza A virus NS2/NEP protein with the amino-terminal part of Nup214
Akyazi, B. Ş., Pirincal, A., Kawaguchi, A., Nagata, K., & Turan, K. (2020) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-1909-49 · Cited by 16
State of the ART (antiretroviral therapy): Long-acting HIV-1 therapeutics
Ravichandran, S., McFadden, W. M., Snyder, A. A., & Sarafianos, S. G. (2024) · Global Health & Medicine · doi:10.35772/ghm.2024.01049 · Cited by 15
Kleinpeter, A. B., Mallery, D. L., Renner, N., Albecka, A., Klarhof, J. O., Freed, E. O., & James, L. C. (2024) · Nature Communications · doi:10.1038/s41467-024-51971-w · Cited by 15
Multifunctionality of F-rich nucleoporins
Heinß, N., Sushkin, M. E., Yu, M., & Lemke, E. A. (2020) · Biochemical Society Transactions · doi:10.1042/bst20200357 · Cited by 15
Connecting HIV ‐1 integration and transcription: a step toward new treatments
Lucic, B., & Lušić, M. (2016) · FEBS Letters · doi:10.1002/1873-3468.12226 · Cited by 17
Direct visualization of HIV-1 core nuclear import and its interplay with the nuclear pore
Hou, Z., Fronik, S., Shen, Y., Chen, L., Thompson, C., Neumann, S., & Zhang, P. (2025) · EMBO Reports · doi:10.1038/s44319-025-00567-6 · Cited by 16
The HIV-1 capsid serves as a nanoscale reaction vessel for reverse transcription
Jennings, J., Bracey, H., Hong, J., Nguyen, D. T., Dasgupta, R., Rivera, A. V., Sluis‐Cremer, N., Shi, J., & Aiken, C. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011810 · Cited by 14
Impact of HIV-1 capsid polymorphisms on viral infectivity and susceptibility to lenacapavir
Hansen, D., Hendricks, M. R., Chang, S., Cai, A., Perry, J. K., Aeschbacher, T., Martin, R., Cihlář, T., & Yant, S. R. (2025) · mBio · doi:10.1128/mbio.00187-25 · Cited by 14
Zhang, X., Sun, L., Xu, S., Shao, X., Li, Z., Ding, D., Jiang, X., Zhao, S., Cocklin, S., Clercq, E. D., et al. (2022) · Molecules · doi:10.3390/molecules27217640 · Cited by 14
Comparison of Biochemical Properties of HIV-1 and HIV-2 Capsid Proteins
Miyazaki, Y., Miyake, A., Doi, N., Koma, T., Uchiyama, T., Adachi, A., & Nomaguchi, M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01082 · Cited by 15
Sarkar, S., Balakrishnan, K., Chintala, K., Mohareer, K., Luedde, T., Vasudevan, A. A. J., Münk, C., & Banerjee, S. (2022) · Viruses · doi:10.3390/v14112503 · Cited by 15
Layish, B., Goli, R., Flick, H., Huang, S., Zhang, R. Z., Kvaratskhelia, M., & Kane, M. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011830 · Cited by 13
Virus–Host Interactions in Retrovirus Integration
Engelman, A. N., & Maertens, G. N. (2018) · Retrovirus-Cell Interactions · doi:10.1016/b978-0-12-811185-7.00004-2 · Cited by 12
Self-citationDesign and Synthesis of New GS-6207 Subtypes for Targeting HIV-1 Capsid Protein
Akther, T., McFadden, W. M., Zhang, H., Kirby, K. A., Sarafianos, S. G., & Wang, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073734 · Cited by 12
Tolomeo, M., Tolomeo, F., & Cascio, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073184 · Cited by 14
Ingram, Z., Fischer, D. K., & Ambrose, Z. (2021) · Viruses · doi:10.3390/v13112237 · Cited by 12
CA Mutation N57A Has Distinct Strain-Specific HIV-1 Capsid Uncoating and Infectivity Phenotypes
Fischer, D. K., Saito, A., Kline, C. E., Cohen, R., Watkins, S. C., Yamashita, M., & Ambrose, Z. (2019) · Journal of Virology · doi:10.1128/jvi.00214-19 · Cited by 12
Host factors that promote retrotransposon integration are similar in distantly related eukaryotes
Rai, S. K., Sangesland, M., Lee, M., Esnault, C., Cui, Y., Chatterjee, A. G., & Levin, H. L. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006775 · Cited by 12
HIV-1 mutants that escape the cytotoxic T-lymphocytes are defective in viral DNA integration
Balasubramaniam, M., Davids, B.-O., Bryer, A., Xu, C., Thapa, S., Shi, J., Aiken, C., Pandhare, J., Perilla, J. R., & Dash, C. (2022) · PNAS Nexus · doi:10.1093/pnasnexus/pgac064 · Cited by 11
Fluorescence Microscopy Assay to Measure HIV-1 Capsid Uncoating Kinetics in vitro
Márquez, C. L., Lau, D., Walsh, J. C., Faysal, K. M. R., Parker, M. W., Turville, S. G., & Böcking, T. (2019) · BIO-PROTOCOL · doi:10.21769/bioprotoc.3297 · Cited by 11
May I Help You with Your Coat? HIV-1 Capsid Uncoating and Reverse Transcription
Arribas, L., Menéndez‐Arias, L., & Betancor, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137167 · Cited by 11
Cyclophilin A facilitates HIV-1 integration
Padron, A., Dwivedi, R., Chakraborty, R., Prakash, P., Kim, K., Shi, J., Ahn, J., Pandhare, J., Luban, J., Aiken, C., et al. (2024) · Journal of Virology · doi:10.1128/jvi.00947-24 · Cited by 10
Mechanistic insights into lenacapavir-induced off-pathway HIV-1 capsid assembly
Gupta, M., Waltmann, C., Renner, N., Wang, Y., James, L. C., Jacques, D. A., Böcking, T., & Voth, G. A. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2524995123 · Cited by 10
Role of Transportin-SR2 in HIV-1 Nuclear Import
Tabasi, M., Nombela, I., Janssens, J., Lahousse, A. P., Christ, F., & Debyser, Z. (2021) · Viruses · doi:10.3390/v13050829 · Cited by 11
Guedán, A., Burley, M., Caroe, E. R., & Bishop, K. N. (2024) · Viruses · doi:10.3390/v16050670 · Cited by 10
How viral proteins bind short linear motifs and intrinsically disordered domains
Madhu, P., Davey, N. E., & Ivarsson, Y. (2022) · Essays in Biochemistry · doi:10.1042/ebc20220047 · Cited by 10
Zhang, X., Sun, L., Xu, S., Huang, T., Zhao, F., Ding, D., Liu, C., Jiang, X., Tao, Y., Kang, D., et al. (2023) · RSC Medicinal Chemistry · doi:10.1039/d3md00134b · Cited by 10
Taylor, I. A., & Fassati, A. (2023) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjad076 · Cited by 9
The nuclear localization signal of CPSF6 governs post-nuclear import steps of HIV-1 infection
Rohlfes, N., Radhakrishnan, R., Singh, P. K., Bedwell, G. J., Engelman, A., Dharan, A., & Campbell, E. M. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1012354 · Cited by 9
Self-citationDecoding the biogenesis of HIV-induced CPSF6 puncta and their fusion with nuclear specklesPreprint
Tomasini, C., Cuche, C., Ay, S., Collard, M., Cui, B., Rashid, M., Bhattacharjee, S., Tello-Rubio, B., Buchrieser, J., Luchsinger, C., et al. (2024) · eLife · doi:10.7554/elife.103725 · Cited by 9
A new class of capsid-targeting inhibitors that specifically block HIV-1 nuclear import
Boulay, A., Quevarec, E., Malet, I., Nicastro, G., Chamontin, C., Perrin, S., Henriquet, C., Pugnière, M., Courgnaud, V., Blaise, M., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00143-w · Cited by 8
Equine Infectious Anemia Virus Cellular Partners Along the Viral Cycle
Schimmich, C., Vabret, A., Zientara, S., & Valle‐Casuso, J. C. (2024) · Viruses · doi:10.3390/v17010005 · Cited by 8
Metadata
- Authors
- Matreyek, K. A., Yücel, S. S., Li, X., & Engelman, A.
- Affiliations
- Harvard University (US)
- Corresponding author
- Engelman, Alan
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-10-10
- Volume
- 9
- Issue
- 10
- Pages
- e1003693
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3795039
- OpenAlex
- W2120902492
- Cited by
- 280
- References
- 91
- Citations by year
- 2026: 10 · 2025: 30 · 2024: 27 · 2023: 17 · 2022: 18 · 2021: 32 · 2020: 25 · 2019: 21 · 2018: 24 · 2017: 13 · 2016: 23 · 2015: 18 · 2014: 20 · 2013: 2
- FWCI
- 9.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (AI052014, R01AI052014)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- Nup153, HIV-1 capsid protein, host-virus protein interaction, equine infectious anemia virus, CPSF6
- MeSH terms
- Binding Sites, Cell Cycle, Cell Line, Cell Nucleus, Humans, Mutation, Protein Binding, HIV-1, HIV Infections, Amino Acid Motifs, Active Transport, Cell Nucleus, Nuclear Pore Complex Proteins, mRNA Cleavage and Polyadenylation Factors, gag Gene Products, Human Immunodeficiency Virus, Hydrophobic and Hydrophilic Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.